Non Invasive Prenatal Testing Market and Forecast to 2021

Market growth can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). With increased patient access to NIPT test, the NIPT market is anticipated to have a positive outlook in the coming years. High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of NIPT test market.

 

Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=76

 

United States is seen as the dominant player in the NIPT test market followed by Germany, China and India in 2015. In the coming years, NIPT test market is expected to witness the highest growth rate in the Asian region, with emphasis on China and India. These countries are expected to increase revenues for the manufacturers of tests involved in NIPT test market.

On the basis of test, MaterniT21 plus test has gain its momentum in 2011 when there was only one NIPT test available in the market. MaterniT21 test market revenue value was US$ XX Million in 2015. It is expected that MaterniT21 plus test will lead the NIPT test market with the market share of more than XX% by the year 2021. Other NIPT tests such as Panorama, Harmony, Verifi, NIFTY and Prerna test have emerged as the promising test in the NIPT test market. The major companies are expanding their tests through collaboration, distribution agreement, strategic alliances and partnerships with clinical laboratories and hospitals.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SEGMENTATION

Global Non-Invasive Prenatal Testing (NIPT) Market – By Test Type

1.    MaterniT21 PLUS

2.    Harmony

3.    NIFTY

4.    Verifi

5.    Panorama

6.    PrenaTest

7.    BambniTest

8.    informaSeq

9.    VisibiliT

10.  Veracity

11.  IONA Test

Global Non-Invasive Prenatal Testing (NIPT) Market – By Country

1.    United States

2.    United Kingdom

3.    Germany

4.    Italy

5.    Spain

6.    France

7.    Switzerland

8.    Sweden

9.    Belgium

10.  Australia

11.  New Zealand

12.  Japan

13.  China

14.  India

15.Brazil

Kidney Transplant Market Research Report Analysis

Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.

Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=75

Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share.United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.

Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France.  Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.

The 10 countries covered in the report are analysed from two viewpoints:

1. Number of Kidney Transplant Performed (2008 – 2021)

2. Kidney Transplant Market (2008 – 2021)

Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:

1.    United States

2.    Germany

3.    France

4.    Italy

5.    United Kingdom

6.    Japan

7.    Argentina

8.    Mexico

9.    Spain

10.  Brazil

Non-Invasive Prenatal Testing Market Report 2018

Non-Invasive Prenatal Test (NIPT)are targeted at the detection of certain specific chromosomal aneuploidies from maternal blood sample in pregnant women at high risk for fetal aneuploidies. Currently, the prenatal testing market is experiencing a paradigm shift from conventional prenatal screening and diagnostic methods to non-invasive prenatal testing. This is mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities.

NIPT is one of the most promising new areas of screening because it delivers highly actionable insights for empowering critical health decisions. The global non-invasive prenatal testing market is segmented on the basis of tests viz; Harmony, MaterniT21 PLUS, PrenaTest, Verifi, BambniTest, Panorama, InformaSeq, Non-Invasive Fetal Trisomy Test (NIFTY), VisibiliT, Veracity and IONA Test. NIPT has experienced substantial growth over the past few years.

MaterniT21 plus test has gain its momentum in 2011 when there was only one NIPT test available in the market. In 2015, The MaterniT21 plus test market revenue decreased with XXX% compared to 2014. MaterniT21 test market revenue value was US$ XXX Million in 2015. Natera has emerged as one of the leading companies, with innovative technologies and a strong commercial base. Natera Panorama test will lead the NIPT market in the forecasting period with the market share of XXX% by the year 2021. Other NIPT tests such as Harmony, Verifi and NIFTY have emerged as the promising test in the NIPT test market. The major companies are expanding their tests through Collaboration, Distribution Agreement, Strategic Alliances and Partnerships with Clinical Laboratories and Hospitals.

DPI Research report titled “Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) – Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021″. The report presents a comprehensive study of the Global NIPT market with market revenue and volume of the tests. market shares for leading NIPT test, comparative analysis of the non–invasive prenatal testing,NIPT implementation in HICs and LMICs, major deals in the NIPT market such as Collaborations, Partnerships, Distribution Agreement, Venture Capital Investment, Merger & Acquisition, Licensing Agreement and Exclusive Agreement. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

Key segments of the Global NIPT market

The 11 NIPT Test covered in the report has been analyzed from 2 viewpoints:

1. NIPT Test Market Revenue (2011 – 2021)

2. NIPT Test Volume (2011 – 2021)

The following are the NIPT test name which is covered in the report.

1)    BambniTest

2)    Harmony

3)    informaSeq

4)    MaterniT21 PLUS

5)    NIFTY

6)    Panorama

7)    PrenaTest

8)    verifi

9)    VisibiliT

10)  Veracity

11)  IONA Test

The report also covers NIPT implementation in High Income Countries and Low – or- Middle Income Countries. The 3 issues for implementation covered are:

1)    Clinical Issues

2)    Ethical Issues

3)    Legal and Regulatory Issues

This report gives access to significant data such as:

  •    Market Growth Drivers
  •    Challenges in the NIPT Test Market
  •    Current Market Trends
  •    Market Forecasting for the Coming Years
  •    Comparative Test Analysis

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources:Questionnaires, Surveystelephonic interviews with industry experts and Observations

Secondary Sources:Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

Read More Details @ http://www.dpiresearch.com/report-details.php?P_ID=49